Talis Biomedical Corporat... (TLIS)
OTC: TLIS
· Real-Time Price · USD
1.06
-0.54 (-33.75%)
At close: Apr 04, 2025, 9:37 AM
Talis Biomedical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -8.85M | -13.04M | -13.46M | -15.68M | -15.03M | -17.83M | -26.93M | -26.02M | -27.01M | -33.05M | -28.65M | -38.42M | -64.47M | -60.49M |
Depreciation & Amortization | n/a | 262K | 614K | 217K | 168K | 174K | 3.56M | 3.92M | 980K | 363K | 937K | 231K | 194K | 216K |
Stock-Based Compensation | 791K | 601K | 1.02M | 1.07M | 1.08M | 1.18M | 1.28M | 1.3M | 1.25M | 1.54M | 3.17M | 2.48M | 1.79M | 1.77M |
Other Working Capital | -4.64M | -1.95M | 1.87M | -722K | -1.59M | -34K | 4.19M | -1.5M | 215K | -7.25M | -15.96M | -33.37M | 27.88M | 344.47M |
Other Non-Cash Items | 1.37M | 4.18M | 3.65M | 441K | 2.67M | 785K | 4.41M | 945K | 599K | 409K | 30K | 485K | 385K | 143K |
Deferred Income Tax | n/a | n/a | -3.65M | 2.77M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -4.64M | 371K | 469K | 42K | -3.16M | -776K | 4.13M | -967K | 2.17M | -13.02M | -16.22M | -39.52M | 28.69M | 35.88M |
Operating Cash Flow | -11.33M | -6.43M | -11.36M | -11.14M | -14.27M | -16.46M | -13.54M | -20.82M | -22.01M | -43.76M | -40.74M | -74.75M | -33.41M | -22.48M |
Capital Expenditures | n/a | n/a | 93K | -70K | -485K | -24K | -49K | -860K | -199K | -507K | -987K | -759K | -422K | -698K |
Cash Acquisitions | n/a | 30K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 84K | 30K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 987K | n/a | n/a | n/a |
Investing Cash Flow | 84K | 30K | 93K | -70K | -485K | -24K | -49K | -860K | -199K | -507K | -987K | -759K | -422K | -698K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 2K | 33K | n/a | n/a | 33K | n/a | 92K | n/a | 314K | 670K | 1M | 80K | 131K |
Financial Cash Flow | n/a | 2K | n/a | n/a | n/a | 33K | n/a | 92K | n/a | 314K | 670K | 1M | -722K | 233.48M |
Net Cash Flow | -11.25M | -6.39M | -11.26M | -11.21M | -14.76M | -16.46M | -13.59M | -21.59M | -22.21M | -43.95M | -41.06M | -74.5M | -34.55M | 210.3M |
Free Cash Flow | -11.33M | -6.43M | -11.26M | -11.21M | -14.76M | -16.49M | -13.59M | -21.68M | -22.21M | -44.27M | -41.73M | -75.51M | -33.83M | -23.18M |